D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
951
DELISTED
Amedisys
AMED
| $14.8M | 0.02% |
152,777
-45,624
| -23% | -$5.44M |
|
952
Xenon Pharmaceuticals
XENE
$6.06B
| $14.8M | 0.02% |
409,563
+83,021
| +25% | +$2.98M |
|
|
SAMA
953
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
| $14.8M | 0.02% |
1,485,000
| – | – |
|
|
KRNL
954
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $14.8M | 0.02% |
1,487,583
+931,988
| +168% | +$9.21M |
|
|
HTPA
955
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $14.7M | 0.02% |
1,479,227
+852,635
| +136% | +$8.46M |
|
|
TCOA
956
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $14.7M | 0.02% |
1,485,000
| – | – |
|
|
AUY
957
DELISTED
Yamana Gold, Inc.
AUY
| $14.7M | 0.02% |
3,248,025
+3,180,261
| +4,693% | +$14.7M |
|
958
CALL
Scotiabank
BNS
$107B
| $14.7M | 0.02% |
309,600
+50,000
| +19% | +$2.86M |
|
959
CALL
American Airlines Group
AAL
$10.1B
| $14.7M | 0.02% |
1,220,800
-48,900
| -4% | -$682K |
|
960
CALL
Intuitive Surgical
ISRG
$127B
| $14.7M | 0.02% |
78,400
| – | – |
|
961
Manulife Financial
MFC
$73.9B
| $14.7M | 0.02% |
935,240
+396,300
| +74% | +$6.95M |
|
|
WRK
962
DELISTED
WestRock Company
WRK
| $14.6M | 0.02% |
473,707
+209,852
| +80% | +$8.29M |
|
963
CALL
Twilio
TWLO
$30B
| $14.6M | 0.02% |
211,600
-74,200
| -26% | -$5.93M |
|
|
PEGR
964
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $14.6M | 0.02% |
1,485,000
| – | – |
|
|
DCPH
965
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.6M | 0.02% |
790,411
+623,526
| +374% | +$9.79M |
|
966
Evolent Health
EVH
$348M
| $14.6M | 0.02% |
406,944
-105,210
| -21% | -$3.71M |
|
967
PUT
Seagate
STX
$194B
| $14.6M | 0.02% |
274,300
+64,300
| +31% | +$4.65M |
|
968
NETSCOUT
NTCT
$2.96B
| $14.6M | 0.02% |
464,887
+26,683
| +6% | +$873K |
|
969
Manhattan Associates
MANH
$11.2B
| $14.5M | 0.02% |
109,007
-31,821
| -23% | -$4.31M |
|
970
PUT
Dell
DELL
$262B
| $14.5M | 0.02% |
423,900
+340,000
| +405% | +$14.3M |
|
|
ROSE
971
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
| $14.5M | 0.02% |
1,422,727
| – | – |
|
972
Estee Lauder
EL
$30.4B
| $14.4M | 0.02% |
66,872
+10,065
| +18% | +$2.57M |
|
973
Cameco
CCJ
$37.6B
| $14.4M | 0.02% |
542,364
+107,739
| +25% | +$2.76M |
|
974
iHeartMedia
IHRT
$543M
| $14.4M | 0.02% |
1,961,199
| – | – |
|
975
Constellium
CSTM
$3.76B
| $14.4M | 0.02% |
1,415,549
+119,867
| +9% | +$1.59M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.